Prostate Cancer Research

Funding research to increase survival and find a cure for men with advanced prostate cancer

Prostate Cancer Research

News Centre

Research Updates

Research Updates

Scottish Medical Consortium approves Olaparib for use in NHSScotland

14 March 2024

Scottish Medical Consortium approves Olaparib for use in NHSScotland

Research Updates

NICE issues Final Draft Guidance recommending Lynparza (Olaparib) with abiraterone for patients with untreated hormone-relapsed metastatic prostate cancer

21 December 2023

NICE issues Final Draft Guidance recommending Lynparza (Olaparib) with abiraterone for patients with untreated hormone-relapsed metastatic prostate cancer

Research Updates

Government announces major prostate cancer screening trial to end needless prostate deaths

21 November 2023

Government announces major prostate cancer screening trial to end needless prostate deaths

Research Updates

Pluvicto™ Update

30 October 2023

Pluvicto™ Update

Research Updates

Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland

9 October 2023

Darolutamide with Docetaxel approved for treatment of mHSPC in Scotland

Research Updates

Exploring men’s psychological adjustment to prostate cancer

8 August 2023

Exploring men’s psychological adjustment to prostate cancer

Research Updates

NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer

18 May 2023

NICE recommends darolutamide with androgen deprivation therapy and docetaxel for patients with hormone-sensitive metastatic prostate cancer

Research Updates

#GiveMenMoreTime – NICE reopens consultation on Pluvicto

2 March 2023

#GiveMenMoreTime – NICE reopens consultation on Pluvicto

All, PCR News, Research Updates

Predicting which cancers will return

24 February 2023

Predicting which cancers will return

Research Updates

TOPiC: Talking with men about treatment Options for Prostatic Cancer

15 December 2022

TOPiC: Talking with men about treatment Options for Prostatic Cancer

PCR News, Research Updates

Unlocking Prostate Cancer Data

7 December 2022

Unlocking Prostate Cancer Data

Research Updates

NICE consults on provisional decision to block NHS access to Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) radioligand therapy for advanced prostate cancer

17 October 2022

NICE consults on provisional decision to block NHS access to Pluvicto® (lutetium (177Lu) vipivotide tetraxetan) radioligand therapy for advanced prostate cancer

Load more